- Home
- FOLD vs QS Comparison
FOLD vs QS Comparison
Compare FOLD & QS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOLD
- QS
- Stock Information
- Founded
- FOLD 2002
- QS 2010
- Country
- FOLD United States
- QS United States
- Employees
- FOLD N/A
- QS N/A
- Industry
- FOLD Biotechnology: Pharmaceutical Preparations
- QS Auto Parts:O.E.M.
- Sector
- FOLD Health Care
- QS Consumer Discretionary
- Exchange
- FOLD Nasdaq
- QS Nasdaq
- Market Cap
- FOLD 2.9B
- QS 2.7B
- IPO Year
- FOLD 2007
- QS N/A
- Fundamental
- Price
- FOLD $8.43
- QS $4.33
- Analyst Decision
- FOLD Strong Buy
- QS Hold
- Analyst Count
- FOLD 9
- QS 5
- Target Price
- FOLD $17.00
- QS $6.06
- AVG Volume (30 Days)
- FOLD 2.6M
- QS 9.7M
- Earning Date
- FOLD 05-08-2025
- QS 04-23-2025
- Dividend Yield
- FOLD N/A
- QS N/A
- EPS Growth
- FOLD N/A
- QS N/A
- EPS
- FOLD N/A
- QS N/A
- Revenue
- FOLD $528,294,999.00
- QS N/A
- Revenue This Year
- FOLD $21.91
- QS N/A
- Revenue Next Year
- FOLD $22.22
- QS N/A
- P/E Ratio
- FOLD N/A
- QS N/A
- Revenue Growth
- FOLD 32.29
- QS N/A
- 52 Week Low
- FOLD $8.36
- QS $4.05
- 52 Week High
- FOLD $12.65
- QS $9.52
- Technical
- Relative Strength Index (RSI)
- FOLD 35.37
- QS 41.62
- Support Level
- FOLD $8.40
- QS $4.38
- Resistance Level
- FOLD $9.26
- QS $4.75
- Average True Range (ATR)
- FOLD 0.25
- QS 0.17
- MACD
- FOLD -0.04
- QS 0.03
- Stochastic Oscillator
- FOLD 7.78
- QS 31.71
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.
About QS QuantumScape Corporation
QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles. It developed an anode-less cell design, which delivers high energy density while lowering material costs and simplifying manufacturing.